XSAT:HAMLET B (Sweden)  
Hamlet Pharma AB logo

Hamlet Pharma AB

kr 4.05 (+1.38%) Aug 18
P/E:
At Loss
P/B:
10.93
Market Cap:
kr 447.64M ($ 42.54M)
Enterprise V:
kr 407.12M ($ 38.69M)
Volume:
21.27K
Avg Vol (2M):
43.56K
Also Trade In:
Volume:
21.27K
Market Cap kr:
447.64M
Market Cap $:
42.54M
PE Ratio:
At Loss
Avg Vol (2-Month):
43.56K
Enterprise Value kr:
407.12M
Enterprise Value $:
38.69M
PB Ratio:
10.93
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Hamlet Pharma AB is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.95
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 46.54
9-Day RSI 49.39
14-Day RSI 50.4
6-1 Month Momentum % -29.23
12-1 Month Momentum % -42.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.43
Quick Ratio 18.43
Cash Ratio 17.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.2
Name Current Vs Industry Vs History
ROE % -36.19
ROA % -29.97
ROIC % -206.98
ROC (Joel Greenblatt) % -54172.22
ROCE % -35.11

Financials (Next Earnings Date:2022-08-26)

XSAT:HAMLET B's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 0
EPS (TTM) (kr) -0.093
Beta 0
Volatility % 36.01
14-Day RSI 50.4
14-Day ATR (kr) 0.320852
20-Day SMA (kr) 4.0915
12-1 Month Momentum % -42.71
52-Week Range (kr) 3.005 - 7.97
Shares Outstanding (Mil) 110.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Hamlet Pharma AB Filings

Document Form Filing Date
No Filing Data